the Fetal Epicardial Thickness in Obese Pregnant Women (EFT)

Pregnancy Complications Clinical Trial

— EFT  

Official title:

The Effect of Myocardial Performance Index and Fetal Epicardial Thickness on Perinatal Outcomes in Obese Pregnant Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05948319
• Other study ID #: 14221/neu
• Status: Completed
• Phase: N/A
• Start date: October 1, 2022
• Est. completion date: April 30, 2023

Study information

• Verified date: July 2023
• Source: Necmettin Erbakan University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

the effects of fetal EFT on fetal cardiac function and fetal and maternal outcomes were investigated in obese pregnant women compared with normal-weight pregnant women.

Description:

All pregnant women underwent a comprehensive fetal anomaly screening. One obstetrician (S.D.) assessed all of the measurements. Every measurement was performed using a convex 2-5 MHz Voluson E8 probe (GE Healthcare, Milwaukee, WI). Fetal biometry, UA, MCA Doppler, cerebroplacental ratio (CPR), modified MPI (mod-MPI), and EFT were assessed in accordance with the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) guidelines

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: April 30, 2023
• Est. primary completion date: April 30, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Obese pregnant women

• normal-weight pregnant women

• 24-40 gestational week

Exclusion Criteria:

Twin pregnancies, structural and chromosomal abnormalities, fetal rhesus isoimmunization, fetal growth restriction, cases with infections detected by maternal serological tests, pregestational or gestational diabetes (All patients underwent a 75-gram glucose load test at 24 weeks to rule out diabetes), preeclampsia, premature rupture of membranes were excluded from the study -

Related Conditions & MeSH terms

• Pregnancy Complications

Intervention

Diagnostic Test:
• Doppler ultrasonography
Doppler study was performed in all cases. perinatal outcomes were evaluated.

Locations

Country	Name	City	State
Turkey	Necmettin Erbakan University	Konya

Sponsors (1)

Lead Sponsor	Collaborator
Necmettin Erbakan University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	birth weight (gram)	fetal outcome	birth 1 week
Primary	stillbirth rate (%)	fetal outcome	birth 1 week
Primary	NICU admission	fetal outcome	6 months